Further, our work highlights other potential druggable genes associated with depression which are not, to our knowledge, currently associated with antidepressant treatment or mood-associated adverse effects. These include the R-type calcium channel gene, Calcium Voltage-Gated Channel Subunit Alpha1 E (CACNA1E), and the nucleosome associated gene, Lysine Methyltransferase 2A (KMT2A).